Ambaw Bellete
CIK: 0002007090
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CG Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Apr 15, 2026CGON
CG Oncology, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
107.5K shares- - Apr 15, 2025CGON
CG Oncology, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
284.8K shares- - Oct 4, 2024CGON
CG Oncology, Inc.
Award(A)DirectStock Option (Right to Buy)
175.5K shares-
1-3 of 3 transactions
About Bellete Ambaw
Bellete Ambaw (SEC CIK 0002007090) files insider reports with the SEC as President and COO of CG Oncology, Inc. (CGON).
Signal8 holds 3 ownership filings by Bellete Ambaw, all Form 4s, filed between Oct 7, 2024 and Apr 16, 2026. Those filings report 3 transactions, from Oct 4, 2024 to Apr 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bellete Ambaw's filings is in DALLAS, TX.
Recent filings by Bellete Ambaw
Other insiders filing for CG Oncology, Inc. (CGON)
- Kalofonos Isabel, Chief Commercial Officer
- POST LEONARD E, Director
- Mulay James, Director
- Liu Brian Guan-Chyun, Director
- Tong Victor Edward Jr, Director
- Rossi Christina, Director